Omeros News

Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Omeros (OMER) and Urogen Pharma (URGN)

TipRanksApr 9 19:40

Omeros Analyst Ratings

BenzingaNov 11, 2023 04:44

Omeros' Clinical Trials Setbacks and Financial Standing Lead to Underperform Rating: An Analysis

TipRanksOct 17, 2023 06:55

UBS Adjusts Omeros Price Target to $4 From $2, Maintains Neutral Rating

MT NewswiresMar 15, 2023 23:15

Bank of America Securities Keeps Their Sell Rating on Omeros (OMER)

TipRanksMar 14, 2023 18:49

Analysts Offer Insights on Healthcare Companies: Omeros (OMER) and SAGE Therapeutics (SAGE)

TipRanksFeb 7, 2023 20:06

Needham Reaffirms Their Hold Rating on Omeros (OMER)

TipRanksFeb 7, 2023 00:56

Omeros Analyst Ratings

Benzinga Analyst RatingsDec 8, 2022 21:32

UBS Downgrades Omeros to Neutral, Lowers Price Target to $2

Benzinga Real-time NewsDec 8, 2022 21:31

Needham Reaffirms Their Hold Rating on Omeros (OMER)

TipRanksNov 10, 2022 19:35

BofA Securities Downgrades Omeros to Underperform Rating From Neutral, Price Target Is $3

MT NewswiresNov 9, 2022 21:57

Omeros Analyst Ratings

Benzinga Analyst RatingsNov 9, 2022 02:46

B of A Securities Downgrades Omeros to Underperform, Announces $3 Price Target

Benzinga Real-time NewsNov 9, 2022 02:46

Omeros Downgraded at Bank of America After FDA Snub for Narsoplimab Appeal

Seeking AlphaNov 9, 2022 01:20